IP Library Granted Patent US 7,195,785
Granted Patent B2
US 7,195,785 · App. 10/480,145 · Granted Mar 27, 2007

Complex mixtures exhibiting selective inhibition of cyclooxygenase-2

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,195,785
App. No.
10/480,145
Granted
Mar 27, 2007
Kind
B2
Abstract

A novel formulation is provided that serves to specifically inhibit the COX-2 mediated inflammatory response in animals. The formulation comprises comprising an effective amount of component I selected from the group consisting of alpha acids and beta acids and an effective amount of at least one component II selected from the group consisting of alpha acids, beta acids, essential oils, fats and waxes, with the proviso that component I and II are not the same compound. The composition provides specific inhibition of cyclooxygenase-2 with little or no effect on cyclooxygenase-1.

Claims (11)

1. A method of treating inflammation comprising administering to an animal suffering symptoms of inflammation a pharmaceutical grade extract of hops comprising an effective amount of tetrahydroisohumulone, and an effective amount of essential oils, fats or waxes, wherein said administration provides about 0.01 to 100 mg per kg body weight per day of tetrahydroisohumulone.

2. The method of claim 1 , wherein the animal displays symptoms of acne rosacea.

3. The method of claim 1 , wherein the animal displays symptoms of psoriasis.

4. The method of claim 1 , wherein the animal displays symptoms of eczema.

5. The method of claims 1 – 4 , wherein said administration provides 0.01 to 100 mg per kg body weight per day of essential oils.

6. The method of any one of claims 1 – 4 , wherein said animal is selected from the group consisting of humans, non-human primates, dogs, cats, birds, horses, reptiles, fish, amphibians and ruminants.

7. The method of any one of claims 1 – 4 , wherein administration is by a means selected from the group consisting of oral, parenteral, topical, transdermal and transmucosal delivery.

8. The method of any one of claims 1 – 4 , wherein said administration is topical.

9. The method of any one of claims 1 – 4 , wherein said pharmaceutical acceptable carrier is selected from the group consisting of coatings, isotonic and absorption delaying agents, binders and adhesives, lubricants, disintegrants, coloring agents, flavoring agents, sweetening agents, absorbants, detergents, and emulsifying agents.

10. The method of any one of claims 1 – 4 , wherein said pharmaceutical grade extract of hops further comprises one or more members selected from the group consisting of antioxidants, vitamins and minerals.

11. The method of any one of claims 1 – 4 , wherein said pharmaceutical grade extract of hops further comprises one or more members selected from the group consisting of proteins, fats, carbohydrates, glucosamine, chondrotin sulfate and amino sugars.

Assignments (9)
TERMINATION AND RELEASE OF PATENT SECURITY AGREEMENT - REEL/FRAME 057981/0156 Recorded Dec 24, 2025
From: FORTRESS CREDIT CORP.
To: METAGENICS LLC (FKA METAGENICS, INC.); METAPROTEOMICS, LLC
Reel/Frame 074057/0392 →
TERMINATION AND RELEASE OF PATENT SECURITY AGREEMENT - REEL/FRAME 058015/0602 Recorded Dec 23, 2025
From: FORTRESS CREDIT CORP.
To: METAGENICS LLC (FKA METAGENICS, INC.); METAPROTEOMICS, LLC
Reel/Frame 074050/0670 →
SECURITY INTEREST Recorded Nov 4, 2021
From: METAGENICS, INC.; METAPROTEOMICS, LLC
To: FORTRESS CREDIT CORP. (AS COLLATERAL AGENT)
Reel/Frame 058015/0602 →
SECURITY INTEREST Recorded Nov 1, 2021
From: METAGENICS, INC.; METAPROTEOMICS, LLC
To: FORTRESS CREDIT CORP., AS COLLATERAL AGENT
Reel/Frame 057981/0156 →
RELEASE OF SECURITY INTEREST Recorded Oct 25, 2021
From: BANK OF AMERICA, N.A.
To: META PROTEOMICS, LLC
Reel/Frame 057909/0199 →
RELEASE OF SECURITY INTEREST Recorded Oct 26, 2009
From: COMERICA BANK
To: METAGENICS, INC.; METAGENICS FAR EAST, INC.; META PROTEOMICS, LLC
Reel/Frame 023423/0951 →
SECURITY AGREEMENT Recorded Oct 15, 2009
From: META PROTEOMICS, LLC
To: BANK OF AMERICA, N.A.
Reel/Frame 023373/0684 →
SECURITY AGREEMENT Recorded Jun 2, 2006
From: METAGENICS, INC.; METAGENICS FAR EAST, INC.; META PROTEOMICS, L.L.C.
To: COMERICA BANK
Reel/Frame 017706/0815 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 10, 2005
From: BABISH, JOHN G.; HOWELL, TERRENCE M.
To: METAPROTEOMICS, LLC
Reel/Frame 016210/0622 →